HIV Archives
Targeting HIV’s “cap”
Feb. 10, 2015—New findings underscore the attractiveness of the HIV capsid – the structure that encloses the viral genome – as a therapeutic target.
Traditional healers contribute to HIV care delays: study
Oct. 2, 2014—If you’re a native of rural Mozambique who contracts HIV and becomes symptomatic, before seeking clinical testing and treatment, you’ll likely consult a traditional healer.
Study tracks new way to fight HIV infection in women
Sep. 11, 2014—Vanderbilt University’s Richard Caprioli, Ph.D., is participating in a national, federally funded collaboration to develop an intravaginal ring capable of delivering antiretroviral drugs to women at risk for HIV infection.
HIV’s impact on B cells
Jan. 15, 2014—Understanding how HIV infection affects immune system B cells may guide strategies for vaccine development.
Defining patient retention
Jul. 15, 2013—Vanderbilt researchers propose guidelines for defining patient retention in clinical studies – an important parameter that affects study conclusions and program evaluations.
Host proteins can control HIV infection
Oct. 5, 2012—The protein APOBEC3G contributes to spontaneous control of HIV-1 in vivo and may provide therapeutic benefits.
Early HIV treatment also can prevent TB: study
Aug. 2, 2012—Anti-retroviral therapy can prevent tuberculosis, even in people with early HIV disease.
Long antibodies better against HIV
Jul. 19, 2012—Understanding how antibodies with long “loops” form may be important for HIV vaccine development.
Spelling out HIV risk in urban China
Jun. 27, 2012—Research reveals clues to HIV risk in Chinese men who have sex with other men.
‘Acid test’ for cervical cancer
Feb. 21, 2012—An inexpensive, low-tech test for cervical cancer may be a good option for screening for the disease among HIV-infected women in developing countries.
